Adenosine A 3 receptor stimulation reduces muscle injury following physical trauma and is associated with alterations in the MMP/TIMP response

Journal of Applied Physiology

Volumn 112, Issue 4, 2012, Pages 658-670

  Urso, Maria L ^a   Wang, Ruibo ^b   Zambraski, Edward J ^a   Liang, Bruce T ^b  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Matrix metalloprotease; Tissue inhibitors of metalloproteases

Indexed keywords

ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; COLLAGEN; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; ARTICLE; C57BL MOUSE; ENZYMOLOGY; EXTRACELLULAR MATRIX; FREEZING; INFLAMMATION; INJURY; MALE; METABOLISM; MOUSE;

ADENOSINE A3 RECEPTOR AGONISTS; ANIMALS; COLLAGEN; EXTRACELLULAR MATRIX; FREEZING; INFLAMMATION; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; RECEPTOR, ADENOSINE A3; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; WOUNDS AND INJURIES;

EID: 84859621907     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00809.2011     Document Type: Article

References (59)

1. Armstrong RB, Ogilvie RW, Schwane JA. Eccentric exercise-induced injury to rat skeletal muscle. J Appl Physiol 54: 80-93, 1983. (Pubitemid 13110554)
2. Bani C, Lagrota-Candido J, Pinheiro DF, Leite PE, Salimena MC, Henriques-Pons A, Quirico-Santos T. Pattern of metalloprotease activity and myofiber regeneration in skeletal muscles of mdx mice. Muscle Nerve 37: 583-592, 2008. (Pubitemid 351590549)
3. Barnes BR, Szelenyi ER, Warren GL, Urso ML. Alterations in mRNA and protein levels of metalloproteinases-2, -9, and -14 and tissue inhibitor of metalloproteinase-2 responses to traumatic skeletal muscle injury. Am J Physiol Cell Physiol 297: Cl501-Cl508, 2009.
4. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105: 477-482, 2002. (Pubitemid 34141705)
5. Choi YC, Dalakas MC. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 54: 65-71, 2000. (Pubitemid 30038739)
6. 3 adenosine receptors alter glutathione status in an organ-specific manner and influence the changes after inhibition of gamma-glutamylcysteine ligase. Free Radic Res 43: 304-311, 2009.
7. 2+Atpase by tertiary butylhydroperoxide. Mol Cell Biochem 237: 85-93, 2002. (Pubitemid 34965796)
8. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 276: 24833-24842, 2001.
9. Furochi H, Tamura S, Mameoka M, Yamada C, Ogawa T, Hirasaka K, Okumura Y, Imagawa T, Oguri S, Ishidoh K, Kishi K, Higashiyama S, Nikawa T. Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts. FEBS Lett 581: 5743-5750, 2007. (Pubitemid 350235424)
10. Furochi H, Tamura S, Takeshima K, Hirasaka K, Nakao R, Kishi K, Nikawa T. Overexpression of osteoactivin protects skeletal muscle from severe degeneration caused by long-term denervation in mice. J Med Invest 54: 248-254, 2007. (Pubitemid 350143738)
11. Ge ZD, Peart JN, Kreckler LM, Wan TC, Jacobson MA, Gross GJ, Auchampach JA. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5=-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther 319: 1200-1210, 2006.
12. Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-81, 1997. (Pubitemid 27387694)
13. Guzman J, Yu JG, Suntres Z, Bozarov A, Cooke H, Javed N, Auer H, Palatini J, Hassanain HH, Cardounel AJ, Javed A, Grants I, Wunderlich JE, Christofi FL. ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis. Inflamm Bowel Dis 12: 766-789, 2006. (Pubitemid 44253762)
14. Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Egginton S, Brown MD, Madri JA, Hudlicka O. Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 279: H1540-H1547, 2000.
15. Hamer PW, McGeachie JM, Davies MJ, Grounds MD. Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat 200: 69-79, 2002. (Pubitemid 34285290)
16. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 296: 803-809, 1993. (Pubitemid 24008200)
17. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275: 12080-12089, 2000. (Pubitemid 30237783)
18. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20: 4782-4793, 2001. (Pubitemid 32848631)
19. Iwabuchi S, Ito M, Hata J, Chikanishi T, Azuma Y, Haro H. In vitro evaluation of low-intensity pulsed ultrasound in herniated disc resorption. Biomaterials 26: 7104-7114, 2005. (Pubitemid 41095532)
20. Jian Liu K, Rosenberg GA. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39: 71-80, 2005. (Pubitemid 40733117)
21. Kandalam V, Basu R, Abraham T, Wang X, Soloway PD, Jaworski DM, Oudit GY, Kassiri Z. TIMP2 deficiency accelerates adverse postmyocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circ Res 106: 796-808, 2010.
22. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Verdiere-Sahuque M, Fardeau M, Alameddine HS. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 205: 158-170, 1999. (Pubitemid 29042665)
23. Kieseier BC, Schneider C, Clements JM, Gearing AJ, Gold R, Toyka KV, Hartung HP. Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain 124: 341-351, 2001. (Pubitemid 32142406)
24. Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 273: 16098-16103, 1998. (Pubitemid 28311379)
25. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84: 649-698, 2004. (Pubitemid 38365495)
26. Kwak HB, Kim JH, Joshi K, Yeh A, Martinez DA, Lawler JM. Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart. FASEB J 25: 1106-1117.
27. Li H, Mittal A, Paul PK, Kumar M, Srivastava DS, Tyagi SC, Kumar A. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J Biol Chem 284: 4439-4450, 2009.
28. Liang BT. Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection. Biochem J 336: 337-343, 1998.
29. Lopes-Ferreira M, Nunez J, Rucavado A, Farsky SH, Lomonte B, Angulo Y, Moura Da Silva AM, Gutierrez JM. Skeletal muscle necrosis and regeneration after injection of Thalassophryne nattereri (niquim) fish venom in mice. Int J Exp Pathol 82: 55-64, 2001. (Pubitemid 32578837)
30. Maddock HL, Gardner NM, Khandoudi N, Bril A, Broadley KJ. Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA. Eur J Pharmacol 477: 235-245, 2003. (Pubitemid 38366396)
31. McCall KE, Duncan CJ. The action of phenazine methosulphate in causing cellular damage in the isolated mouse soleus muscle preparation. Pathobiology 63: 278-282, 1995. (Pubitemid 26120362)
32. McCall KE, Duncan CJ. Independent pathways causing cellular damage in mouse soleus muscle under hypoxia. Comp Biochem Physiol 94: 799-804, 1989. (Pubitemid 20028248)
33. Mu X, Urso ML, Murray K, Fu F, Li Y. Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice. Am J Pathol 177: 2399-2410, 2010.
34. Mukherjee R, Bruce JA, McClister DM Jr, Allen CM, Sweterlitsch SE, Saul JP. Time-dependent changes in myocardial structure following discrete injury in mice deficient of matrix metalloproteinase-3. J Mol Cell Cardiol 39: 259-268, 2005. (Pubitemid 40995015)
35. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000. (Pubitemid 30123793)
36. Ogawa T, Nikawa T, Furochi H, Kosyoji M, Hirasaka K, Suzue N, Sairyo K, Nakano S, Yamaoka T, Itakura M, Kishi K, Yasui N. Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am J Physiol Cell Physiol 289: C697-C707, 2005. (Pubitemid 41192679)
37. Ohtake Y, Tojo H, Seiki M. Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle. J Cell Sci 119: 3822-3832, 2006. (Pubitemid 44614434)
38. Osenkowski P, Toth M, Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol 200: 2-10, 2004. (Pubitemid 38720616)
39. Parsons M, Young L, Lee JE, Jacobson KA, Liang BT. Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J 14: 1423-1431, 2000. (Pubitemid 30439751)
40. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 158: 1582-1590, 1997. (Pubitemid 127469511)
41. Reeps C, Pelisek J, Seidl S, Schuster T, Zimmermann A, Kuehnl A, Eckstein HH. Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology 76: 243-252, 2009.
42. Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A, Cowled PA. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 23: 260-269, 2002. (Pubitemid 41079468)
43. Rullman E, Norrbom J, Stromberg A, Wagsater D, Rundqvist H, Haas T, Gustafsson T. Endurance exercise activates matrix metalloproteinases in human skeletal muscle. J Appl Physiol 106: 804-812, 2009.
44. 3 receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol 62: 1137-1146, 2002. (Pubitemid 35222505)
45. Seguin CA, Bojarski M, Pilliar RM, Roughley PJ, Kandel RA. Differential regulation of matrix degrading enzymes in a TNFalpha-induced model of nucleus pulposus tissue degeneration. Matrix Biol 25: 409-418, 2006. (Pubitemid 44512122)
46. Seguin CA, Pilliar RM, Madri JA, Kandel RA. TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration. Spine 33: 356-365, 2008. (Pubitemid 351286527)
47. Stambaugh K, Elliott GT, Jacobson KA, Liang BT. Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel. Circulation 99: 3300-3307, 1999. (Pubitemid 29293442)
48. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338, 1995.
49. Tatsumi R. Mechano-biology of skeletal muscle hypertrophy and regeneration: possible mechanism of stretch-induced activation of resident myogenic stem cells. Anim Sci J 81: 11-20, 2010.
50. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288: R345-R353, 2005. (Pubitemid 40129595)
51. Urso ML, Szelenyi ER, Warren GL, Barnes BR. Matrix metalloprotease-3 and tissue inhibitor of metalloprotease-1 mRNA and protein levels are altered in response to traumatic skeletal muscle injury. Eur J Appl Physiol 109: 963-972, 2010.
52. 3 receptor stimulation induces protection of skeletal muscle from eccentric exercise-mediated injury. Am J Physiol Regul Integr Comp Physiol 299: R259-R267, 2010.
53. Wang Y, Tang Z, Xue R, Singh GK, Shi K, Lv Y, Yang L. Combined effects of TNF-α, IL-1, and HIF-1β on MMP-2 production in ACL fibroblasts under mechanical stretch: an in vitro study. J Orthop Res 29: 1008-1014, 2011.
54. Warren GL, Hulderman T, Liston A, Simeonova PP. Toll-like and adenosine receptor expression in injured skeletal muscle. Muscle Nerve 44: 85-92, 2011.
55. Yamada M, Sankoda Y, Tatsumi R, Mizunoya W, Ikeuchi Y, Sunagawa K, Allen RE. Matrix metalloproteinase-2 mediates stretch-induced activation of skeletal muscle satellite cells in a nitric oxide-dependent manner. Int J Biochem Cell Biol 40: 2183-2191, 2008.
56. Yang Z, Berr SS, Gilson WD, Toufektsian MC, French BA. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 109: 1161-1167, 2004. (Pubitemid 38332621)
57. 3 receptors in skeletal muscle ischemia and reperfusion injury. Am J Physiol Heart Circ Physiol 293: H3685-H3691, 2007. (Pubitemid 350230914)
58. Zimowska M, Brzoska E, Swierczynska M, Streminska W, Moraczewski J. Distinct patterns of MMP-9 and MMP-2 activity in slow and fast twitch skeletal muscle regeneration in vivo. Int J Dev Biol 52: 307-314, 2008. (Pubitemid 351554718)
59. 2+ release in rat heart. Cardiovasc Res 50: 56-64, 2001. (Pubitemid 32244385)